Market research reports, consulting: Global Market Insights Inc.

Home > Healthcare > Medical Devices > Therapeutic Devices > gastrointestinal bleeding treatment market

Gastrointestinal Bleeding Treatment Market Share

Report ID: GMI8601 Published Date: March 2024Report Format: PDF
Download Free Sample
Summary
Table of Content

Gastrointestinal Bleeding Treatment Market Share

The market is characterized by the presence of established players offering a range of products for gastrointestinal bleeding treatment. Key players compete on factors such as product diversity, product efficacy, safety profile, pricing, distribution networks, and brand reputation. Continuous focus on innovation, strategic partnerships, mergers, and acquisitions are common strategies employed by market players to gain a competitive edge in this dynamic and evolving market.

Prominent players operating in the gastrointestinal bleeding treatment industry are as mentioned below:

  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group
  • ERBE Elektromedizin GmbH
  • Medtronic PLC
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • Pfizer Inc.
  • STERIS PLC
  • US Medical Innovations
Author: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :

What is the value of the gastrointestinal bleeding treatment industry?+

Gastrointestinal bleeding treatment market size was USD 808 million in 2023 and is expected to register 7.9% CAGR from 2024-2032 owing to the rising cases of gastrointestinal disorders such as peptic ulcers, gastritis, and colorectal cancer worldwide.

Why is the demand for endoscopic hemostatic devices growing?+

Gastrointestinal bleeding treatment industry from the endoscopic hemostatic devices segment recorded USD 498.8 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to their high efficacy and minimally invasive nature.

How big is the North America gastrointestinal bleeding treatment market?+

North America gastrointestinal bleeding treatment industry held 41.6% share in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the high prevalence of gastrointestinal disorders in the region.

Who are the key leaders in the gastrointestinal bleeding treatment industry?+

CONMED Corporation, Cook Group, ERBE Elektromedizin GmbH, Medtronic PLC, Olympus Corporation, Ovesco Endoscopy AG, Pfizer Inc., STERIS PLC, and US Medical Innovations, are some of the major gastrointestinal bleeding treatment companies worldwide.

Gastrointestinal Bleeding Treatment Market Scope

Related Reports

Buy Now

Premium Report Details

Download Free Sample